Cited by 193Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsMesenchymal stem cell research

Senescent cells: a therapeutic target for cardiovascular disease

Open access
Childs, Bennett G., Li, Hu, van Deursen, Jan M.·2018·Journal of Clinical Investigation

Abstract

Cellular senescence, a major tumor-suppressive cell fate, has emerged from humble beginnings as an in vitro phenomenon into recognition as a fundamental mechanism of aging. In the process, senescent cells have attracted attention as a therapeutic target for age-related diseases, including cardiovascular disease (CVD), the leading cause of morbidity and mortality in the elderly. Given the aging global population and the inadequacy of current medical management, attenuating the health care burden of CVD would be transformative to clinical practice. Here, we review the evidence that cellular senescence drives CVD in a bimodal fashion by both priming the aged cardiovascular system for disease and driving established disease forward. Hence, the growing field of senotherapy (neutralizing senescent cells for therapeutic benefit) is poised to contribute to both prevention and treatment of CVD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci95146

Cites

180 of 180 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The SASP is a protracted and chronic source of inflammatory and other plaque-destabilizing factors, gradually contributing to atherosclerosis pathogenesis.

    “Emerging experimental evidence indicates that, in contrast to an acute inflammatory response, the SASP is a protracted and chronic source of inflammatory and other plaque-destabilizing factors,9,10 gradually contributing to atherosclerosis pathogenesis.”
  • Cellular senescence is accompanied by a pro-inflammatory phenotype known as the senescence-associated secretory phenotype (SASP), which produces pro-inflammatory cytokines, metalloproteinases, and other factors.

    “Cellular senescence is defined as an irreversible cell cycle arrest (mechanism outlined in Figure 1)8 and is accompanied by a pro-inflammatory phenotype. The phenotype is referred to as the senescence-associated secretory phenotype (SASP), producing pro-inflammatory cytokines [interleukin (IL)-1α, IL-1β, IL-6, IL-8, IL-18, CCL-2, tumour necrosis factor α (TNF-α)], metalloproteinases (MMP-1, -2, -3”
  • Senescent endothelial cells in atherosclerotic plaques secrete VCAM-1 to recruit and differentiate monocytes into foam cell macrophages.

    “Importantly, a fraction of dysfunctional endothelial cells in atherosclerotic plaques is senescent (Minamino et al, 2002) and secretes vascular cell adhesion molecule 1 (VCAM‐1) to recruit and differentiate monocytes into foam cell macrophages (Davignon & Ganz, 2004; Childs et al, 2018).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

1 retracted

Flagged first, then by citations

1 of the 181 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. John M. Eisenberg Center for Clinical Decisions and Communications Science. Treatments for open-angle glaucoma: a review of the research for adults. In: Comparative Effectiveness Review Summary Guides for Consumers [Internet]. Rock- ville, Maryland, USA: Agency for Healthcare Research and Quality; 2005. https://www.ncbi. nlm.nih.gov/books/NBK131775/. Accessed Janu- ary 29, 2018.

Cited by

Sorted by citations

Authors
Childs, B. G., Li, H., & van Deursen, J. M.
Affiliations
Mayo Clinic (US)
Venue
Journal of Clinical Investigation
Published
2018-04-02
Volume
128
Issue
4
Pages
1217-1228
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W2795134170
Cited by
192
References
181
Citations by year
2026: 17 · 2025: 21 · 2024: 13 · 2023: 24 · 2022: 32 · 2021: 35 · 2020: 27 · 2019: 16 · 2018: 7
FWCI
2.80
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • Glenn Foundation for Medical Research
  • Fondation pour la Recherche Médicale
  • National Institutes of Health
  • National Institute on Aging (R01AG057493, T32AG049672)
  • National Cancer Institute (R01CA126828, R01CA096985)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Health Sciences › Medicine › Genetics › Mesenchymal stem cell research
Keywords
cellular senescence, senolytics, senotherapy, cardiovascular disease, aging, age-related diseases, senolytic therapy, cardiovascular aging
MeSH terms
Aged, Aging, Animals, Cardiovascular Diseases, Cardiovascular System, Humans, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review